NASDAQ : SMTI
Sanara MedTech Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 32.83 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 301.64M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 301.64M |
| Enterprise Value | 334.75M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 9.19M |
| Shares Outstanding | 9.19M |
| Shares Change (YoY) | +1.59% |
| Shares Change (QoQ) | -3.60% |
| Owned by Insiders (%) | 31.29% |
| Owned by Institutions (%) | 21.78% |
| Float | 3.77M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 98.74 |
| PS Ratio | 2.75 |
| Forward PS | 4.97 |
| PB Ratio | 38.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 66.97 |
| P/OCF Ratio | 52.97 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 3.05 |
| EV / EBITDA | 26.26 |
| EV / EBIT | 32.63 |
| EV / FCF | 74.33 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.58 |
| Quick Ratio | 2.24 |
| Debt / Equity | 6.12 |
| Debt / EBITDA | 3.64 |
| Debt / FCF | 10.78 |
| Interest Coverage | 1.41 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -1.32% |
| Return on Assets (ROA) | 7.64% |
| Return on Invested Capital (ROIC) | 9.34% |
| Return on Capital Employed (ROCE) | 18.11% |
| Weighted Average Cost of Capital (WACC) | 10.92% |
| Revenue Per Employee | $1.02M |
| Profits Per Employee | -$296,435 |
| Employee Count | 108 |
| Asset Turnover | 1.31 |
| Inventory Turnover | 2.20 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.19 |
| 52-Week Price Change | +11.52% |
| 50-Day Moving Average | 34.51 |
| 200-Day Moving Average | 25.48 |
| Relative Strength Index (RSI) | 27.25 |
| Average Volume (20 Days) | 142,888 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 374,810 |
| Short Previous Month | 354,542 |
| Short % of Shares Out | 4.08% |
| Short % of Float | 9.95% |
| Short Ratio (days to cover) | 2.20 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 109.81M |
| Gross Profit | 102.16M |
| Operating Income | 10.26M |
| Pretax Income | -286,274 |
| Net Income | -32.01M |
| EBITDA | 12.75M |
| EBIT | 10.26M |
| Loss Per Share | -$3.69 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 15.42M |
| Total Debt | 48.53M |
| Net Cash | -33.11M |
| Net Cash Per Share | -$3.60 |
| Equity (Book Value) | 7.93M |
| Book Value Per Share | 0.86 |
| Working Capital | 19.71M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 5.69M |
| Capital Expenditures | -1.19M |
| Depreciation & Amortization | 2.49M |
| Net Borrowing | n/a |
| Free Cash Flow | 4.50M |
| FCF Per Share | $0.49 |
Margins
| Measure | Value |
|---|
| Gross Margin | 93.03% |
| Operating Margin | 9.34% |
| Pretax Margin | -0.26% |
| Profit Margin | -29.15% |
| EBITDA Margin | 11.61% |
| EBIT Margin | 9.34% |
| FCF Margin | 4.10% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.59% |
| Shareholder Yield | -1.59% |
| Earnings Yield | -11.23% |
| FCF Yield | 1.49% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $35.00 |
| Price Target Difference | 6.61% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 13.88% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | May 10, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.05 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |